The Prince Edward Island BioAlliance has announced the appointment of Dr. Mark Redmond as Director of Incubation Services for the Emergence Incubator.
Mark will work to expand Emergence’s impact on new ventures, support entrepreneurs and cultivate strong networks across the region and across Canada.
Mark has a broad range of expertise that will enable him to excel in this role. With a PhD in Molecular Biology and Immunology, he has experience as a medical researcher, intellectual property manager, senior health system administrator, education leader and entrepreneur.
“I think one of my greatest strengths is as a systems thinker—someone who sees the opportunity behind issues and challenges,” said Mark Redmond. “I’m looking forward to working with our innovators and partners to help us achieve our respective goals and further grow the bio-economy in Atlantic Canada, seizing the opportunities for today and for our future.”
Born in Liverpool, England, Mark brings to our community a portfolio of technical experience ranging from human health and veterinary medicine to biochemicals, from botanical and marine sources to sensors and devices, and from remote application monitoring to manufacturing and systems’ simulation.
Mark developed his own research into global business success: launched more than 20 new, patent-protected products, including pharmaceuticals, diagnostics and medical devices, in Canadian, American, European, Australian and Japanese markets. In recognition of this work, he received the Frost & Sullivan Product Innovation Award, the BioAlberta Entrepreneur of the Year title, and a nomination as Ernst & Young Canadian Entrepreneur of the Year.
To support talented entrepreneurs and enterprise, Mark co-founded The A100, a self-funding community of seasoned founders and executives who led technology companies. The A100 focuses on having the entrepreneur develop the full potential of the businessperson, not just the business.
Rory Francis, BioAlliance CEO said, “I am pleased to welcome Mark to Emergence. Mark’s impressive scientific background, private sector experience with startups, capital formation and IPOs, along with his experience in the academic world, will be very valuable to us and our partners as we continue our mission of incubating early stage bio-based companies across Atlantic Canada and growing the bioscience cluster.”